Submission of Annual Report for the Financial Year 2024-25 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

02 Sep 2025, 01:57PM

21.15

-4.90%

Board Meeting

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Outcome Of The Board …

BSE India

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

25 Aug 2025

21.15

-4.90%

SAST

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading Window

BSE India

Closure Trading Window for amalgamation of Venmax Drugs and Pharmaceuticals Limited with Hatri Pharma Private Limited.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

25 Aug 2025

21.15

-4.90%

Board Meeting

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Pursuant To Regulation 29 …

BSE India

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 ,inter alia, to consider and approve matters related to Annual General Meeting, Amalgamation of the Company and Increase of Authorised Share Capital.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

16 Aug 2025

21.15

-4.90%

Board Meeting

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Outcome Of Board Meeting …

BSE India

The Board of Directors at its meeting held today i.e. August 16, 2025, have approved the allotment of 20,55,000 Equity shares of Rs. 10/- each upon conversion of 20,55,000 share warrants to the holders of share warrants who have exercised their rights for conversion of warrants into equivalent number of Equity Shares.

pdf

Venmax Drugs & Pharmaceuticals Ltd.

08 Aug 2025

21.15

-4.90%

Board Meeting

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Allotment Of Equity Shares …

BSE India

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2025 ,inter alia, to consider and approve Allotment of Equity Shares pursuant to conversion of Convertible Equity Share Warrants.

pdf

Is Venmax Drugs & Pharmaceuticals Ltd. worth buying?

8 Votes:

Buy 87.5%

Sell 12.5%